tirzepatide and glaucoma Cataract: They Are Not the Same! Both affect your vision, but in very different ways! - Glaucoma damages the optic nerve (often without early symptoms) Glaucoma Management

was dosed similarly, administrated subcutaneously at 1 mg/kg/week using a 1 cc syringe with the final volume of 4 mL/kg

The FDA has issued these warnings based on rodent studies where GLP-1 medications caused hyperplasia of medullary C-cells, leading to medullary C-cell carcinoma

After four weeks, doctors will increase the dose to 5 mg each week

Overall, the data from the central injections suggest that both forebrain and hindbrain sites are involved in GLP-1R agonist-induced hypodipsia

For guidance on which drinks have the least impact, see best alcohol to drink on tirzepatide

Giannakou M, Saltiki K, Mantzou E, Loukari E, Philippou G, Terzidis K et al (2018) The effect of obesity and dietary habits on oxidative stress in Hashimotos thyroiditis